Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe De Wals

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 14, 2024
Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health communityPhilippe De Wals, Michaël Desjardins
International Journal of Health Policy and Management|May 17, 2018
Soda Taxes: The Importance of Analysing Policy Processes Comment on "The Untapped Power of Soda Taxes: Incentivising Consumers, Generating Revenue, and Altering Corporate Behaviours"Yann Le Bodo, Philippe De Wals
International Journal of Environmental Research and Public Health|March 3, 2018
Individual and School Correlates of Adolescent Leisure Time Physical Activity in Quebec, CanadaJosé Massougbodji, Alexandre Lebel, Philippe De Wals
Health and Quality of Life Outcomes|July 28, 2010
Quality of life of children and their caregivers during an AOM episode: development and use of a telephone questionnaireEve Dubé, Philippe De Wals, Manale Ouakki
Vaccine|March 7, 2006
Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluationPhilippe De Wals, Pierre Trottier, Jacques Pépin
Chronic Diseases in Canada|February 20, 2007
Validity of death and stillbirth certificates and hospital discharge summaries for the identification of neural tube defects in Quebec CityFassiatou Tairou, Philippe De Wals, Adrien Bastide
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 19, 2020
Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspectivePhilippe De Wals, Dick Menzies, Maziar Divangahi
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 8, 2025
Effectiveness of the four-component protein-based meningococcal vaccine against <i>Neisseria gonorrhoeae</i> infections: Mounting evidence and public health implications for CanadaPhilippe De Wals, Yen-Giang Bui, Michaël Desjardins
Clinical Therapeutics|November 20, 2009
Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation modelPhilippe De Wals, Steven Black, Ray Borrow, et al.
Expert Review of Vaccines|June 20, 2019
Kingdon's Multiple Streams Framework and the Analysis of Decision-Making Processes Regarding Publicly-Funded Immunization ProgramsPhilippe De Wals, Maria-Eugenia Espinoza-Moya, Daniel Béland
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 14, 2024
Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health communityPhilippe De Wals, Michaël Desjardins
International Journal of Health Policy and Management|May 17, 2018
Soda Taxes: The Importance of Analysing Policy Processes Comment on "The Untapped Power of Soda Taxes: Incentivising Consumers, Generating Revenue, and Altering Corporate Behaviours"Yann Le Bodo, Philippe De Wals
International Journal of Environmental Research and Public Health|March 3, 2018
Individual and School Correlates of Adolescent Leisure Time Physical Activity in Quebec, CanadaJosé Massougbodji, Alexandre Lebel, Philippe De Wals
Health and Quality of Life Outcomes|July 28, 2010
Quality of life of children and their caregivers during an AOM episode: development and use of a telephone questionnaireEve Dubé, Philippe De Wals, Manale Ouakki
Vaccine|March 7, 2006
Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluationPhilippe De Wals, Pierre Trottier, Jacques Pépin
Chronic Diseases in Canada|February 20, 2007
Validity of death and stillbirth certificates and hospital discharge summaries for the identification of neural tube defects in Quebec CityFassiatou Tairou, Philippe De Wals, Adrien Bastide
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 19, 2020
Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspectivePhilippe De Wals, Dick Menzies, Maziar Divangahi
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 8, 2025
Effectiveness of the four-component protein-based meningococcal vaccine against <i>Neisseria gonorrhoeae</i> infections: Mounting evidence and public health implications for CanadaPhilippe De Wals, Yen-Giang Bui, Michaël Desjardins
Clinical Therapeutics|November 20, 2009
Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation modelPhilippe De Wals, Steven Black, Ray Borrow, et al.
Expert Review of Vaccines|June 20, 2019
Kingdon's Multiple Streams Framework and the Analysis of Decision-Making Processes Regarding Publicly-Funded Immunization ProgramsPhilippe De Wals, Maria-Eugenia Espinoza-Moya, Daniel Béland
Pageof 13